his.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Complementary and alternative medicine use in lung cancer patients in eight European countries
a School of Nursing, University of Manchester, Coupland III, Coupland Street, Manchester M13 9PL, UK.
Greek Oncology Nursing Society, Athens, Greece.
Greek Oncology Nursing Society, Athens, Greece.
Gazi University Hospital, Ankara, Turkey.
Show others and affiliations
2006 (English)In: Complementary Therapies in Clinical Practice, ISSN 1744-3881, Vol. 12, no 1, 34-39 p.Article in journal (Refereed) Published
Abstract [en]

This paper presents findings from a cross-sectional survey about the use of complementary and alternative medicine (CAM) in patients with lung cancer, forming part of a larger study. Data from 111 lung cancer patients in 8 countries in Europe were collected through a descriptive 27-item questionnaire. The data suggest that 23.6% of the lung cancer patients used CAM after the diagnosis with cancer. The most popular CAM modalities were herbal medicine (48.1%), medicinal teas (11.5%), homeopathy (11.5%), use of animal extracts (11.5%) and spiritual therapies (11.5%). Herbal use increased by three times after the diagnosis of cancer. Patients seemed quite satisfied with the CAM used. They were also spending on average about 142 Euros monthly on CAM therapies or remedies. The most common motivation to use CAM was to increase the body's ability to fight the cancer. Main sources of information about CAM were friends and family. As CAM is increasingly used by patients with lung cancer, it is important to be able to assist patients make an appropriate decision by discussing the issue of CAM openly, providing reassurance and communicating safe and appropriate information to patients. © 2005 Elsevier Ltd. All rights reserved.

Place, publisher, year, edition, pages
Elsevier, 2006. Vol. 12, no 1, 34-39 p.
Keyword [en]
Alternative medicine, Complementary medicine, Complementary therapies, Lung cancer, adult, aged, article, cross-sectional study, decision making, epidemiology, Europe, family, female, friend, human, Israel, lung tumor, male, methodology, middle aged, motivation, patient attitude, patient education, psychological aspect, questionnaire, socioeconomics, statistics, treatment outcome, Turkey (republic), utilization review, Aged, 80 and over, Cross-Sectional Studies, Friends, Health Care Surveys, Humans, Lung Neoplasms, Patient Acceptance of Health Care, Questionnaires, Socioeconomic Factors, Turkey
Identifiers
URN: urn:nbn:se:his:diva-7076DOI: 10.1016/j.ctcp.2005.09.007PubMedID: 16401528Scopus ID: 2-s2.0-30344451710OAI: oai:DiVA.org:his-7076DiVA: diva2:601448
Available from: 2013-01-29 Created: 2013-01-29 Last updated: 2013-01-29

Open Access in DiVA

No full text

Other links

Publisher's full textPubMedScopus
In the same journal
Complementary Therapies in Clinical Practice

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 33 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf